Federal award
BIOQ PHARMA INCORPORATED
W81XWH0710074
Assistance
Obligated and Ceiling
- Obligated (net)
- $5,116,144.00
- Potential value
- —
- Current value
- —
- Gross positive obligations
- $5,116,446.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- BIOQ PHARMA INCORPORATED · U1LKB452LKY7
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- WEST PHARMACEUTICAL SERVICES, INC. · JP72MQBU2RJ4
- Awarding agency
- Department of Defense · sub-agency 9700
- Funding agency
- —
- Assistance listing (CFDA)
- CFDA 12.420
- FAIN
- W81XWH0710074
- Award type code
- 04
- Actions
- 4 · Dec 4, 2007 to Jun 2, 2014
- Why it is listed
- a program on the reviewed research-assistance allowlist (DoD, DOE or NASA from $10k, or eligible DHS research)
Action History4
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jun 2, 2014 | FY2014 | 0005 | FX | −$302.00 | — |
| Jan 27, 2010 | FY2010 | 0003 | B1 | $1,628,205.00 | — |
| Mar 3, 2009 | FY2009 | 0002 | B1 | $1,855,411.00 | — |
| Dec 4, 2007 | FY2008 | 0001 | B1 | $1,632,830.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.